pembrolizumab in development Buyback: 6,000 Cr at 1,150/share signals management confidence in long-term value 19) Cipla US - Crossing $400 Mn Quarterly, Ventolin CGT Milestone FY26 US: ~$780 Mn | First AB-rated generic Ventolin with CGT approval Ciplas US business has been built methodically on respiratory leadership (inhaler franchise), and the generic Ventolin approval with Comparative Bioequivalence Study/CGT represents a significant competitive moat
Protein + Creatine Omega-3 + D3 Magnesium + Zinc Electrolytes + Creatine Most people take these ALONE, but stacking them is where the real results show
MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J
MD Diet clients experience a reduction in their blood sugar levels as well as their cholesterol
Interestingly, researchers found that participants who were switched to a placebo (inactive treatment) nearly halfway through regained an average of 14% of their body weight